Ypsomed Announces Plans to Invest $195.4 M, creating 62 New Jobs in Holly Springs, North Carolina

Ottobre 10, 2025

Ypsomed, the leading developer and manufacturer of injection systems for the self-administration of liquid medicine, today announced plans to invest $195.4 million in its first North American manufacturing facility.

“Establishing our new production site in the United States marks an important milestone in Ypsomed’s global growth strategy. We have deliberately chosen Holly Springs, a location at the very heart of our industry, close to our customers. The cooperative approach of the local authorities, the excellent infrastructure, and the proximity to top-tier universities provide ideal conditions for our future growth. This environment will allow us to attract the skilled workforce we need and to further strengthen our position as a leading supplier of self-injection systems worldwide”, said Simon Michel, CEO of Ypsomed.

Headquartered in Burgdorf, Switzerland, Ypsomed operates globally with over 2,000 employees across multiple production sites. The North American manufacturing facility will expand production capacity and global partnerships. Ypsomed’s plans initially call for 62 new jobs, with the intention to grow significantly in the coming years.